GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Novacyt SA (FRA:NYZ) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Novacyt (FRA:NYZ) Future 3-5Y EPS without NRI Growth Rate : N/A (As of Sep. 21, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Novacyt Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Novacyt's Future 3-5Y EPS without NRI Growth Rate is N/A.


Competitive Comparison of Novacyt's Future 3-5Y EPS without NRI Growth Rate

For the Medical Devices subindustry, Novacyt's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novacyt's Future 3-5Y EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Novacyt's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Novacyt's Future 3-5Y EPS without NRI Growth Rate falls into.



Novacyt  (FRA:NYZ) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.


Novacyt Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Novacyt's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Novacyt Business Description

Industry
Traded in Other Exchanges
Address
13, Avenue Morane Saulnier, Velizy-Villacoublay, FRA, 78140
Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. The company operates its business through the following business segments. Primerdesign is the designer, manufacturer, and marketer of molecular 'real-time' qPCR testing devices and reagents in the areas of infectious diseases based in Southampton, UK: IT-IS International segment develops PCR devices for the life sciences and food testing industry and Corporate segment.

Novacyt Headlines

No Headlines